In this study, we examined the role of coding variation in breast cancer in multiple populations, focusing on a set of 17 candidate steroid hormone coactivator and corepressor-related genes selected based on their ability to interact with the estrogen receptor transcription complex and potentially modulate response to estrogen in breast tissue. This evidence concerns the gene ESR1 and breast carcinoma.